Technical Analysis for IMRN - Immuron Limited

Grade Last Price % Change Price Change
grade C 3.7 -2.37% -0.09
IMRN closed down 2.37 percent on Monday, November 11, 2019, on 82 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Up
See historical IMRN trend table...

Date Alert Name Type % Chg
Upper Bollinger Band Walk Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Jack-in-the-Box Bullish Bullish Swing Setup -2.37%
Upper Bollinger Band Walk Strength -2.37%
Inside Day Range Contraction -2.37%
Above Upper BB Strength -2.37%
Upper Bollinger Band Touch Strength -2.37%
Expansion Breakout Bullish Swing Setup -5.61%
Pocket Pivot Bullish Swing Setup -5.61%
Wide Range Bar Range Expansion -5.61%

Older signals for IMRN ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Immuron Limited, a microbiome company, focuses on developing and commercializing oral immunotherapeutics for the treatment of various gut medicated diseases in Australia and internationally. The company operates through Research and Development, and HyperImmune Products segments. It has a technology platform that enables a shorter development therapeutic cycle. The company markets and sells Travelan for the prevention of travellers’ diarrhea. Its lead product candidate IMM-124E is in Phase 2b clinical trials for NASH and ASH. The company also has other preclinical immunotherapy pipeline products targeting immune-related diseases. Immuron Limited has a research and development collaboration agreement with the Walter Reed Army Institute of Research (WRAIR) for the development of a Shigella vaccine; and Naval Medical Research Center for the testing of Travelan in cell lines of campylobacter and enterotoxigenic escherichia coli. The company was founded in 1994 and is based in Blackburn North, Australia.
Medicine Diseases Immunotherapy Microbiology Diarrhea Bacteria Gram Negative Bacteria Immunotherapeutics Immune Related Diseases Tropical Diseases Waterborne Diseases
Is IMRN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 9.25
52 Week Low 2.231
Average Volume 80,228
200-Day Moving Average 4.4599
50-Day Moving Average 3.0804
20-Day Moving Average 3.4153
10-Day Moving Average 3.51
Average True Range 0.2385
ADX 40.67
+DI 33.7986
-DI 7.1227
Chandelier Exit (Long, 3 ATRs ) 3.5136
Chandelier Exit (Short, 3 ATRs ) 3.6855
Upper Bollinger Band 3.8092
Lower Bollinger Band 3.0214
Percent B (%b) 0.86
BandWidth 23.066788
MACD Line 0.1759
MACD Signal Line 0.1399
MACD Histogram 0.036
Fundamentals Value
Market Cap 12.07 Million
Num Shares 3.26 Million
EPS -2.08
Price-to-Earnings (P/E) Ratio -1.78
Price-to-Sales 14.94
Price-to-Book 3.14
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.12
Resistance 3 (R3) 4.12 3.97 4.05
Resistance 2 (R2) 3.97 3.87 3.98 4.03
Resistance 1 (R1) 3.84 3.80 3.77 3.84 4.00
Pivot Point 3.69 3.69 3.66 3.70 3.69
Support 1 (S1) 3.56 3.59 3.49 3.56 3.40
Support 2 (S2) 3.41 3.52 3.42 3.37
Support 3 (S3) 3.28 3.41 3.35
Support 4 (S4) 3.28